Emtricitabine: a once-daily nucleoside reverse transcriptase inhibitor.

@article{Modrzejewski2004EmtricitabineAO,
  title={Emtricitabine: a once-daily nucleoside reverse transcriptase inhibitor.},
  author={Krysten A Modrzejewski and Ronald A Herman},
  journal={The Annals of pharmacotherapy},
  year={2004},
  volume={38 6},
  pages={1006-14}
}
OBJECTIVE To review the pharmacology, virology, pharmacokinetics, safety, and efficacy of the nucleoside reverse transcriptase inhibitor (NRTI) emtricitabine. DATA SOURCES English-language reports were accessed using MEDLINE (1966-June 2003) and the Iowa Drug Information Service database (1966-June 2003) using emtricitabine and Coviracil as key words. (Coviracil was the proposed trade name for the product prior to approval.) The Internet was also searched using the terms HIV/AIDS conferences… CONTINUE READING